Showing results (1271-1280 of 1,324) with videos related to

Sort By:
Pageof 133
JAMA Network Open|September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation TherapyChelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.
Advances in Radiation Oncology|October 30, 2018
Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapyTommy Sheu, Sarah A Milgrom, Therese Y Andraos, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2016
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Zeinab Abou Yehia, George N Mikhaeel, Grace Smith, et al.
Blood|October 18, 2017
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentationMani Akhtari, Sarah A Milgrom, Chelsea C Pinnix, et al.
British Journal of Haematology|December 23, 2017
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphomaJay P Reddy, Mike Hernandez, Jillian R Gunther, et al.
Head & Neck|April 4, 2017
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphomaChelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
American Journal of Hematology|November 23, 2016
Dorsal column myelopathy after intrathecal chemotherapy for leukemiaChelsea C Pinnix, Linda Chi, Elias J Jabbour, et al.
Journal of the National Cancer Institute|January 30, 2026
Imaging pitfalls in pediatric, adolescent, and young adult hodgkin lymphoma: a SEARCH for CAYAHL initiative to bridge multidisciplinary patient careNawar Dakhallah, Jonas Steglich, Claire Gowdy, et al.
British Journal of Haematology|August 24, 2017
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?Sarah A Milgrom, Chelsea C Pinnix, Hubert Chuang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2018
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin LymphomaYago Nieto, Peter F Thall, Junsheng Ma, et al.
Pageof 133